Maria Santos Martínez

Consejo Nacional de Investigaciones Científicas y Técnicas

Also affiliated with Universidad Nacional de Córdoba, GlaxoSmithKline (France), Research Centre in Biological Chemistry of Córdoba, GMV Innovating Solutions (Spain)

MedicineComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Lead Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series for the Treatment of Malaria”.

Lead Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series for the Treatment of Malaria

Journal of Medicinal Chemistry(2020)10.1021/acs.jmedchem.0c00311

N/A

0DataRank · unranked

37 citations

Xiaoyi Deng, Karen L. White, Farah El Mazouni, John White, David M. Shackleford +24 more

Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti‐malaria Activity in Humanized Mice

Angewandte Chemie International Edition(2021)10.1002/anie.202015845

N/A

0DataRank · unranked

40 citations

Hao Zhang, John D. Ginn, Annie Leung, Yi J. Liu, Mayako Michino +21 more

Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti‐malaria Activity in Humanized Mice

Angewandte Chemie(2021)10.1002/ange.202015845

N/A

0DataRank · unranked

5 citations

Hao Zhang, John D. Ginn, Annie Leung, Yi J. Liu, Mayako Michino +21 more

Identification of β-Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic Institutions

ACS Infectious Diseases(2022)10.1021/acsinfecdis.1c00570

N/A

0DataRank · unranked

25 citations

Jun Zhang, Landys Lopez Quezada, Julia Roberts, Yan Ling, Madeleine Wood +39 more

GSK2556286 is a novel antitubercular drug candidate effective in vivo with the potential to shorten tuberculosis treatment

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.04.479214

N/A

0DataRank · unranked

11 citations

Maria Santos Martínez, Olalla Sanz, Beatriz Urones, Jorge Esquivias, Heena Soni +25 more